CVS Health Corp. (Melville Shoe) (CVS)

CONSUMER STAPLES: RETAIL - FOOD & DRUG
SIC: RETAIL-DRUG STORES AND PROPRIETARY STORES

ONE CVS DR. WOONSOCKET, RI 02895

Melville Shoe corp. operated retail stores selling shoes (principally men's shoes) under the trade names of "john Ward Men's Shoes," Thom McAn Shoe Co.," and "Frank Tod."
CVS Caremark Corporation (CVS Caremark) is a health care provider in the United States. It is a pharmacy services company and provides value for its customers by managing pharmaceutical costs and improving health care outcomes through its pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; approximately 7,000 CVS/pharmacy retail stores; retail-based health clinic subsidiary, MinuteClinic, and through its online pharmacy, CVS.com. The Company operates in two business segments: Pharmacy Services segment and Retail Pharmacy segment.

Data based on most recent fiscal year report
Market Cap63.393 Billion Shares Outstanding1.013 Billion Avg Volume11.59 Million
1-Yr BETA vs S&P TR Current Ratio1.02 Quick Ratio0.52
View SEC Filings from CVS instead.
Q2 2019 All Institutions Hedge Funds 1
To trade CVS now:
Filers who had this stock in their top 10: 44 9 (0.93%)
13F Filers holding this stock: 1587 132 (13.64%)
Aggregate 13F shares on 06/30/2019: 985.639 Million 73.475 Million
Aggregate 13F shares on 03/31/2019: 1.005 Billion 72.289 Million
Percent change: -1.95% 1.64%
Funds creating new positions: 120 19
Funds Adding to an existing position: 716 52
Funds closing out their position: 146 27
Funds reducing their position: 642 48
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

41.3 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

41.3 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DENTON DAVID M

  • Director
30,210 2019-11-07 1

BRENNAN TROYEN A EVP AND CHIEF MEDICAL OFFICER

  • Officer
100,927 2019-11-04 3

COSBY MARK CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
101,696 2019-11-01 0

RYAN THOMAS M

  • Director
108,004 2019-11-01 0

ROSENBERG SHELI Z

  • Director
1,143,574 2019-11-01 0

FARAH ROGER N

  • Director
0 2019-10-15 3

RICE DERICA W

  • Director
1,358 2019-09-30 2

FLUM JOSHUA MATTHEW EVP, ENT STRATEGY & DIGITAL

  • Officer
36,467 2019-09-30 7

AGUIRRE FERNANDO

  • Director
749 2019-09-30 5

DORMAN DAVID W

  • Director
18,342 2019-09-27 2

BORATTO EVA C EVP & CFO

  • Officer
55,476 2019-09-12 3

BISACCIA LISA

  • Director
22,603 2019-08-29 2

BROWN C DAVID II

  • Director
95,192 2019-08-15 2

SWIFT RICHARD J

  • Director
69,699 2019-06-07 1

WHITE TONY L

  • Director
77,452 2019-06-07 1

SCHAPIRO MARY L

  • Director
12,134 2019-06-01 1

GOLD STEPHEN J

  • Director
15,487 2019-05-24 0

FOULKES HELENA

  • Director
0 2019-05-23 0

MCLURE HOWARD A

  • Director
75,365 2019-05-23 0

FINLEY SARA

  • Director
10,974 2019-05-23 0

WELDON WILLIAM C

  • Director
0 2019-05-20 1

KRAFT ROBERT O.

  • Director
0 2019-05-17 0

FINUCANE ANNE A.

  • Director
22,201 2019-05-16 1

MILLON JEAN PIERRE

  • Director
93,726 2019-05-16 1

DEPARLE NANCY ANN

  • Director
14,713 2019-05-16 1

BRACKEN RICHARD M

  • Director
13,722 2019-05-16 1

DECOUDREAUX ALECIA A

  • Director
0 2019-05-16 1

LUDWIG EDWARD J

  • Director
20,787 2019-05-16 5

BERTOLINI MARK T

  • Director
112,294 2019-05-16 5

BODINE CHRIS W

  • Director
19,606 2019-04-30 0

LYNCH KAREN S

  • Director
0 2019-04-18 5

ROBERTS JONATHAN C EVP & CHIEF OPERATING OFFICER

  • Officer
305,358 2019-04-01 2

MERLO LARRY J PRESIDENT AND CEO

  • Officer
  • Director
1,510,086 2019-04-01 4

MORIARTY THOMAS M EVP & GENERAL COUNSEL

  • Officer
110,371 2019-04-01 2

HOURICAN KEVIN EVP & PRESIDENT, CVS PHARMACY

  • Officer
22,148 2019-04-01 2

LOTVIN ALAN EVP, TRANSFORMATION

  • Officer
37,820 2019-04-01 2

CLARK JAMES DAVID SVP, CONT & CHIEF ACCT OFFICER

  • Officer
9,135 2019-04-01 3

RICKARD DAVID B

  • Director
No longer subject to file 2018-05-30 0

JOYNER J. DAVID EVP, SALES & ACCOUNT SERVICES

  • Officer
No longer subject to file 2017-04-01 0

SUSSMAN ANDREW EVP, CLINICAL SERVICES

  • Officer
No longer subject to file 2017-04-01 0

PICCOLO C A

  • Director
No longer subject to file 2016-01-27 0

LOFBERG PER GH EVP

  • Officer
422,938 2015-01-02 0

WILLIAMS KRISTEN GIBNEY

  • Director
73,318 2013-05-09 0

DANIELS LAIRD SVP, CONT & CHIEF ACCT OFFICER

  • Officer
19,430 2013-04-01 0

HEARD MARIAN L

  • Director
11,353 2012-11-08 0

MCGUIGAN STUART M

  • Director
No longer subject to file 2012-08-21 0

SGARRO DOUGLAS A EVP AND CLO

  • Officer
108,489 2012-05-11 0

BANKS EDWIN M

  • Director
24,187 2012-03-14 0

MURRAY TERRENCE

  • Director
96,293 2011-11-02 0

JOYCE WILLIAM H

  • Director
0 2010-11-04 0

FERDINANDI V MICHAEL SENIOR VICE PRESIDENT

  • Officer
73,757 2009-08-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BRENNAN TROYEN A - Officer EVP AND CHIEF MEDICAL OFFICER

2019-11-04 M 23,604 d 0 100,927.06 direct

BRENNAN TROYEN A - Officer EVP AND CHIEF MEDICAL OFFICER

2019-11-04 S 23,604 $68.00 d 84,317 100,927.06 direct yes

BRENNAN TROYEN A - Officer EVP AND CHIEF MEDICAL OFFICER

2019-11-04 M 23,604 $54.53 a 107,921 100,927.06 direct

FLUM JOSHUA MATTHEW - Officer EVP, ENT STRATEGY & DIGITAL

2019-09-30 M 17,703 $54.53 a 36,163 36,467.05 direct

FLUM JOSHUA MATTHEW - Officer EVP, ENT STRATEGY & DIGITAL

2019-09-30 M 17,703 d 0 36,467.05 direct

FLUM JOSHUA MATTHEW - Officer EVP, ENT STRATEGY & DIGITAL

2019-09-30 S 17,703 $63.00 d 18,460 36,467.05 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments